RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. LYFE Capital
L

LYFE Capital portfolio

LYFE Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. It led 1 of the 2 rounds it joined. Its most recent investment on record is Aspen Neuroscience's $115M Series B+ round in November 2025, alongside S32, Revelation Partners, Prebys Ventures and 6 others. That company is in Health and bio. It has co-invested with S32, OrbiMed and Revelation Partners, most often S32 (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Rounds led: 1 of 2.
Capital in their rounds: $262.5M.
Latest deal: Aspen Neuroscience · Nov 20, 2025.

What LYFE Capital invests in

How LYFE Capital invests

StageDealsCapital in rounds
Series B+ 2 100%$262.5M
YearDealsCapital in rounds
2022 1 50%$147.5M
2025 1 50%$115M

Share is of the 2 rounds on Recent Funding that name LYFE Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

LYFE Capital portfolio companies

CompanyRound with LYFE CapitalTotal raisedLatest raise
AAspen Neuroscience
Health and bio
Series B+ · $115M$339MNov 20, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists LYFE Capital, which is a subset of its real portfolio. API: /api/v1/investors/lyfe-capital (get a free API key). More: the most active VC firms and new venture capital funds.